FIELD: medicine.
SUBSTANCE: method involves introducing hypotensive means by means of instillations. Eye drops of emoxipin are instilled 20-30 min later twice a day during 4-8 weeks. The treatment course is repeated in 2-3 months.
EFFECT: improved vision function; normalized hemodynamic values.
1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR TREATING OPEN ANGLE GLAUCOMA | 1999 | 
 | RU2173123C2 | 
| METHOD FOR TREATING PRIMARY OPEN ANGLE GLAUCOMA | 1997 | 
 | RU2144343C1 | 
| METHOD FOR TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 0 | 
 | SU1648452A1 | 
| METHOD OF SELECTING PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA FOR SELECTIVE LASER TRABECULOPLASTY | 2019 | 
 | RU2726462C1 | 
| ANTIGLAUCOMATOUS PREPARATION | 2000 | 
 | RU2191013C2 | 
| ANTIGLAUCOMATOUS AGENT | 1997 | 
 | RU2128486C1 | 
| METHOD OF PREVENTING THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 | 
 | RU2796891C1 | 
| METHOD FOR PREDICTING CLINICAL VARIANTS OF GLAUCOMA IN PATIENTS WITH MYOPIC REFRACTION | 2003 | 
 | RU2242914C1 | 
| METHOD FOR LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA FOLLOWING MINIMALLY INVASIVE NONPENETRATING DEEP SCLERECTOMY | 2014 | 
 | RU2576811C1 | 
| METHOD FOR COMPLEX TREATING ISCHEMIC VARIANT OF GLAUCOMA IN PATIENTS WITH MYOPIC REFRACTION | 2004 | 
 | RU2281759C2 | 
Authors
Dates
2005-01-10—Published
2003-07-15—Filed